Brhma Gau Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 76.03%
- Profit Growth 10.25%
- Ebitda 18.31%
- Net Worth 76.08%
- Total Assets 3.63%
About Brhma Gau Pharma
Brhma Gau Pharma Private Limited (BGPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 December 2016 (Eight years and one month 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shweta Vaish and Gaurav Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24297DL2016PTC309664
- Company No.
309664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Brhma Gau Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Vaish  | Director | 04-Jan-2021 | Current |
| Gaurav Gupta | Director | 04-Jan-2021 | Current |
Financial Performance of Brhma Gau Pharma.
Brhma Gau Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 76.03% increase. The company also saw a substantial improvement in profitability, with a 10.25% increase in profit. The company's net worth Soared by an impressive increase of 76.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brhma Gau Pharma?
In 2021, Brhma Gau Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uthkarshya Crop Care Private LimitedShweta Vaish and Gaurav Gupta are mutual person
- Nandana Krishi Products Private Limited
Shweta Vaish and Gaurav Gupta are mutual person
- Brutus Infra Tech Private Limited
Shweta Vaish and Gaurav Gupta are mutual person
- Varunavi Infotech Private Limited
Shweta Vaish and Gaurav Gupta are mutual person
- E-Ashram Infotech
Shweta Vaish and Gaurav Gupta are mutual person
- Saar Medicare Private Limited
Shweta Vaish and Gaurav Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Brhma Gau Pharma?
Unlock and access historical data on people associated with Brhma Gau Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brhma Gau Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brhma Gau Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
